Andrew Anighoro[Author] - Search Results

Year	Number of Results
2012	1
2013	1
2014	3
2015	3
2016	3
2017	1
2018	2
2020	2
2021	1
2022	3
2023	1
2024	0

1

Underappreciated Chemical Interactions in Protein-Ligand Complexes.

Anighoro A. Anighoro A. Methods Mol Biol. 2020;2114:75-86. doi: 10.1007/978-1-0716-0282-9_5. Methods Mol Biol. 2020. PMID: 32016887 Review.

2

Deep Learning in Structure-Based Drug Design.

Anighoro A. Anighoro A. Methods Mol Biol. 2022;2390:261-271. doi: 10.1007/978-1-0716-1787-8_11. Methods Mol Biol. 2022. PMID: 34731473

3

Polypharmacology: challenges and opportunities in drug discovery.

Anighoro A, Bajorath J, Rastelli G. Anighoro A, et al. J Med Chem. 2014 Oct 9;57(19):7874-87. doi: 10.1021/jm5006463. Epub 2014 Jun 25. J Med Chem. 2014. PMID: 24946140 Review.

4

Enhancing Chemogenomics with Predictive Pharmacology.

James T, Sardar A, Anighoro A. James T, et al. Among authors: anighoro a. J Med Chem. 2020 Nov 12;63(21):12243-12255. doi: 10.1021/acs.jmedchem.0c00445. Epub 2020 Jul 6. J Med Chem. 2020. PMID: 32573226

5

Learning protein-ligand binding affinity with atomic environment vectors.

Meli R, Anighoro A, Bodkin MJ, Morris GM, Biggin PC. Meli R, et al. Among authors: anighoro a. J Cheminform. 2021 Aug 14;13(1):59. doi: 10.1186/s13321-021-00536-w. J Cheminform. 2021. PMID: 34391475 Free PMC article.

6

RECOVER identifies synergistic drug combinations in vitro through sequential model optimization.

Bertin P, Rector-Brooks J, Sharma D, Gaudelet T, Anighoro A, Gross T, Martínez-Peña F, Tang EL, Suraj MS, Regep C, Hayter JBR, Korablyov M, Valiante N, van der Sloot A, Tyers M, Roberts CES, Bronstein MM, Lairson LL, Taylor-King JP, Bengio Y. Bertin P, et al. Among authors: anighoro a. Cell Rep Methods. 2023 Oct 23;3(10):100599. doi: 10.1016/j.crmeth.2023.100599. Epub 2023 Oct 4. Cell Rep Methods. 2023. PMID: 37797618 Free PMC article.

7

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.

Timmons JA, Anighoro A, Brogan RJ, Stahl J, Wahlestedt C, Farquhar DG, Taylor-King J, Volmar CH, Kraus WE, Phillips SM. Timmons JA, et al. Among authors: anighoro a. Elife. 2022 Jan 17;11:e68832. doi: 10.7554/eLife.68832. Elife. 2022. PMID: 35037854 Free PMC article.

8

Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effects.

Canovas Nunes S, De Vita S, Anighoro A, Autelitano F, Beaumont E, Klingbeil P, McGuinness M, Duvert B, Harris C, Yang L, Pokharel SP, Chen CW, Ermann M, Williams DA, Xu H. Canovas Nunes S, et al. Among authors: anighoro a. Blood Cancer J. 2022 Apr 14;12(4):64. doi: 10.1038/s41408-022-00663-z. Blood Cancer J. 2022. PMID: 35422065 Free PMC article.

9

A Hybrid Virtual Screening Protocol Based on Binding Mode Similarity.

Anighoro A, Bajorath J. Anighoro A, et al. Methods Mol Biol. 2018;1824:165-175. doi: 10.1007/978-1-4939-8630-9_9. Methods Mol Biol. 2018. PMID: 30039406

10

Identification of 4-aryl-1H-pyrrole[2,3-b]pyridine derivatives for the development of new B-Raf inhibitors.

Pinzi L, Anighoro A, Bajorath J, Rastelli G. Pinzi L, et al. Among authors: anighoro a. Chem Biol Drug Des. 2018 Jul;92(1):1382-1386. doi: 10.1111/cbdd.13185. Epub 2018 Mar 8. Chem Biol Drug Des. 2018. PMID: 29469983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year